Differences In HTA Acceptance Rates Across Disease Areas: A Comparison Between Four HTA Agencies

被引：0
|
作者：
Vadlamudi, N. K. [1 ]
Griffiths, E. A. [2 ]
机构：
[1] Parexel Int, Hyderabad, Andhra Pradesh, India
[2] PAREXEL, London, England
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.766
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP174
引用
收藏
页码：A287 / A287
页数：1
相关论文
共 50 条
  • [1] ACCEPTANCE OF SURROGATE ENDPOINTS BY HTA AGENCIES IN EUROPE
    Es-Skali, I. J.
    Nijhuis, T.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A484 - A484
  • [2] WHY ARE THERE DIFFERENCES IN HTA RECOMMENDATIONS ACROSS COUNTRIES? A SYSTEMATIC COMPARISON OF HTA DECISION PROCESSES FOR A SAMPLE OF ORPHAN DRUGS IN FOUR COUNTRIES
    Nicod, E.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A540 - A540
  • [3] COMPARISON OF HEALTH TECHNOLOGY ASSESSMENT (HTA) RANKINGS BY GERMAN AND FRENCH HTA AGENCIES
    Hu, I
    Zheng, J.
    Hu, X. H.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A96 - A97
  • [4] DIFFERENCES IN GUIDANCE ON PRO EVIDENTIARY REQUIREMENTS ACROSS KEY EUROPEAN HTA AGENCIES
    Chassany, O.
    van Engen, A.
    Lai, L.
    Borhade, K.
    Ravi, M.
    Harnett, J.
    Chen, C., I
    Quek, R. G. W.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S505 - S505
  • [5] BRIDGING HTA AGENCIES ACROSS EUROPE: A SYSTEMATIC APPROACH TO CATEGORIZE EVOLVING AGENCIES
    Nagy, L.
    Kamal-Bahl, S.
    Brandtmueller, A.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A268 - A268
  • [6] COMPARISON OF HTA DOSSIER REQUIREMENTS ACROSS EUROPE
    Casamayor, M.
    Van Engen, A.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A310 - A311
  • [7] GLOBAL ONCOLOGY ACCESS - THE RELATIVE DIFFICULTY OF REIMBURSEMENT ACROSS FOUR HEALTH TECHNOLOGY ASSESSMENT (HTA) AGENCIES
    Nguyen, K.
    Forsythe, A.
    Azimpour, K.
    Vu, B. K.
    Tomaras, D.
    [J]. VALUE IN HEALTH, 2020, 23 : S68 - S68
  • [8] A SYSTEMATIC FRAMEWORK FOR COMPARING METHODS, PROCEDURES, AND IMPACT ACROSS HTA AGENCIES
    Schwarzer, R.
    Siebert, U.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A337 - A338
  • [9] REIMBURSEMENT DECISION LANDSCAPE FOR ORPHAN DRUGS ACROSS SIX HTA AGENCIES
    Mittal, L. K.
    Banerjee, P.
    Kapoor, A.
    Ligade, V. S.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A257 - A257
  • [10] COMPARISON OF ECONOMIC EVALUATION BETWEEN THREE MAJOR HTA AGENCIES. IS THERE A FRENCH TOUCH?
    Levy, P.
    de Paz, B.
    Guigand, G.
    Porte, F.
    Carion, P. L.
    Minacori, R.
    Popot, C.
    Bendebba, L.
    Dede, Kossi S.
    Peirone, V
    Renard, C.
    Vorimore, A.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A558 - A559
12345